1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Andon Health Co., Ltd. Class A

Andon Health Co., Ltd. Class A

SSZSE:002432
54.02
CNY
+1.98
(+3.80%)
10.24EPS
6.83P/E
32.94BMarket Cap
Oct 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.89
1.25
1.08
1.16
1.37
1.33
1.59
4.64
5.27
57.68
7.27
5.92
3.15
2.55
Basic EPS, GAAP
-0.02
0.03
-0.41
0.04
-0.38
0.03
0.15
0.56
2
35.14
2.81
3.81
5.23
10.35
Free Cash Flow per Basic Share
-0.29
-0.37
-0.44
-0.29
-0.34
-0.67
-0.24
0.94
0.49
39.48
3.5
2.09
-0.99
- -
Dividend per Share
- -
0.01
0.03
0.01
0.03
0.01
0.02
0.02
0.08
0.71
2.67
0.44
0.43
1.46
Book Value per Share
2.01
2.04
1.64
3.56
3.16
3.65
3.84
4.35
5.97
40.36
39.38
42.08
46.96
49.65
Tangible Book Value per Share
1.82
1.83
1.42
2.12
1.6
2.23
2.62
3.43
5.16
39.85
39.19
41.92
46.76
49.27
Basic Weighted Avg Shares
458
340
368
362
436
423
443
433
455
456
445
438
433
425
Sales/Revenue/Turnover
408
425
398
420
598
564
706
2,008
2,397
26,315
3,231
2,592
1,366
1,086
Operating Margin (%)
-3.83
-19.51
-32.66
-33
-29.09
-20.27
-22.53
23.06
40.12
70.97
26.36
27.26
-21.72
-33.86
Depreciation Expense
11
21
25
35
47
55
60
63
89
106
105
66
74
- -
Net Income, GAAP
-9
10
-151
14
-166
13
66
242
909
16,030
1,252
1,669
2,267
4,402
Effective Tax Rate (%)
- -
15.45
- -
- -
- -
- -
- -
1.22
6.53
9.72
14.62
14.56
10.2
14.28
Profit Margin (%)
-2.25
2.4
-37.89
3.45
-27.74
2.25
9.41
12.07
37.91
60.92
38.74
64.38
165.99
405.39
Working Capital
489
456
290
998
424
675
923
1,155
1,821
12,396
10,470
11,517
7,426
2,693
LT Debt
- -
- -
- -
306
- -
73
198
176
34
30
314
1,201
1,478
1,778
Total Equity
748
759
609
1,542
1,369
1,565
1,599
1,822
2,836
20,025
19,824
21,491
22,035
23,333
Return on Invested Capital (%)
- -
2.02
- -
- -
- -
- -
- -
11.61
33.57
139.85
6.6
7.79
8.65
15.47
Return on Capital (%)
- -
1.81
- -
- -
- -
- -
- -
12.55
32.68
132.27
5.58
6.9
9
15.86
Return on Common Equity (%)
-1.22
1.35
-22.05
1.35
-11.4
0.86
4.1
13.66
38.2
142.96
6.45
8.35
10.65
19.76

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,203
4,385
6,515
LT Borrowings
1,452
2,107
1,760
LT Finance Leases
27
22
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
465
465
466
Market Capitalization
18,616
34,223
32,940

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
11,936
13,382
9,637
Cash, Cash Equivalents & STI
10,683
8,389
9,267
Accounts Receivable, Net
48
44
64
Inventories
204
203
212
Total Current Liabilities
4,510
4,560
6,943
Payables & Accruals
- -
- -
- -
ST Debt
4,203
4,385
6,515
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
84.4%
134.32%
2.53%
Free Cash Flow
720.6%
1,532.56%
-147.23%
Net Income, GAAP
114.33%
383.23%
35.84%
Sales/Revenue/Turnover
111.42%
172.47%
-47.32%
Total Cash Common Dividend
147.18%
282.04%
-1.97%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
762
589
741
500
2,592
2025
507
258
- -
296
1,366
2026
301
230
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.56
0.84
1.82
0.68
3.81
2025
0.6
1.5
- -
1.62
5.23
2026
0.7
6.48
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.25
0.06
0.12
0.44
2025
0.03
0.19
- -
0.06
0.43
2026
0.04
1.16
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yi Liu
Full Time Employees
1,249
Sector
Health technology
Industry
Medical specialties
Address
No. 3 Jinping Road Tianjin TI China 300190
IPO Date
Jun 10, 2010
Website
jiuan.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Andon Health Co., Ltd. (002432.SZ) researches, develops, manufactures, and sells health electronics, smart hardware, and medical instruments principally for home use; its core products encompass blood pressure monitors, blood glucose meters, thermometers, pulse oximeters, nebulizers, TENS units, massagers, body fat scales, pregnancy rapid tests, fetal heart rate meters, COVID-19 test kits, nasal irrigators, insect bite healers, red light allergy relievers, and wearable devices tracking blood oxygen, ECG, heart rate, weight, body fat, sleep, and exercise under brands including iHealth, alongside original design manufacturer/original equipment manufacturer offerings and mobile medical communications equipment. Founded in 1995 and headquartered in Tianjin, China, the company operates globally through subsidiaries in Silicon Valley, Paris, Beijing, and Singapore, serving domestic and overseas markets in personal health management, chronic disease monitoring, and smart healthcare via an integrated platform of hardware, mobile applications, and cloud services. In February 2025, its wholly-owned subsidiary Andon Hong Kong completed the acquisition of the remaining 20% stake in iHealth Inc. from Xiaomi Investment for $45.91 million, achieving 100% ownership and enhancing control over its key overseas brand and IVD expansion including diabetes management solutions; additionally, in August 2025, Andon Health led a Series A+ strategic investment in Chromai Technologies to bolster capabilities in high-end scientific instrumentation such as ultra-high-performance liquid chromatography systems.